BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 4604198)

  • 1. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
    Fraser HF
    Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198
    [No Abstract]   [Full Text] [Related]  

  • 2. Subjective effects of narcotic antagonists.
    Haertzen CA
    Adv Biochem Psychopharmacol; 1973; 8(0):383-98. PubMed ID: 4795096
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
    Cowan A
    Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992
    [No Abstract]   [Full Text] [Related]  

  • 4. Assays of antagonistic activity of narcotic antagonists in man.
    Gorodetzky CW
    Adv Biochem Psychopharmacol; 1973; 8(0):291-7. PubMed ID: 4604130
    [No Abstract]   [Full Text] [Related]  

  • 5. The actions of narcotic antagonists in morphine-dependent rhesus monkeys.
    Villarreal JE; Karbowski MG
    Adv Biochem Psychopharmacol; 1973; 8(0):273-89. PubMed ID: 4212386
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic 14-hydroxymorphinan narcotic antagonists.
    Pachter IJ
    Adv Biochem Psychopharmacol; 1973; 8(0):57-62. PubMed ID: 4153098
    [No Abstract]   [Full Text] [Related]  

  • 8. Self administration: positive and negative reinforcing properties of morphine antagonists in rhesus monkeys.
    Hoffmeister F; Wuttke W
    Adv Biochem Psychopharmacol; 1973; 8(0):361-9. PubMed ID: 4212335
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists.
    Jacob JJ; Barthelemy CD; Tremblay EC; Colombel MC
    Adv Biochem Psychopharmacol; 1973; 8(0):299-318. PubMed ID: 4800176
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic effects of select narcotic antagonists in mice.
    Nuite JA; Harris LS
    Adv Biochem Psychopharmacol; 1973; 8(0):417-25. PubMed ID: 4794888
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon.
    McMillan DE; Wolf PS; Carchman RA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):443-58. PubMed ID: 5481709
    [No Abstract]   [Full Text] [Related]  

  • 12. Bridged amino tetralins.
    Freed ME; Potoski JR; Freed EH; Gluckman MI; Malis JL
    Adv Biochem Psychopharmacol; 1973; 8(0):137-44. PubMed ID: 4211844
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of narcotics and antagonists as related to drug abuse.
    Elliott HW
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):459-61. PubMed ID: 5566729
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological adjuncts in the treatment of opiate dependence.
    Resnick RB
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).
    Martin WR; Fraser HF; Gorodetzky CW; Rosenberg DE
    J Pharmacol Exp Ther; 1965 Dec; 150(3):426-36. PubMed ID: 5322320
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine.
    Hill HE; Bell EC; Wikler A
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute effects of opiate agonists, partial agonists and antagonists on brain monoamines in the rat.
    Fennessy MR; Laska FJ
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):60-70. PubMed ID: 485705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists in the 5-phenyl-benzomorphan series.
    Clarke FH; Hill RT; Saelens JK; Yokoyama N
    Adv Biochem Psychopharmacol; 1973; 8(0):81-9. PubMed ID: 4211809
    [No Abstract]   [Full Text] [Related]  

  • 19. Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys.
    Goldberg SR; Hoffmeister F; Schlichting U; Wuttke W
    J Pharmacol Exp Ther; 1971 Nov; 179(2):268-76. PubMed ID: 5002481
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of physical dependence on morphine, codeine and meperidine in the rat by continuous infusion.
    Teiger DG
    J Pharmacol Exp Ther; 1974 Sep; 190(3):408-15. PubMed ID: 4472146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.